Weeranun Bode, MD
Clinical Cardiac Electrophysiology · Austin, TXNPI 1205064839
Payments from drug & device makers
What this record shows
This record is dominated by grants: $145,404 of the $177,659 with a category attached, or 81.8%. 23 manufacturers reported payments, led by Medtronic at 43.8% of the total. Reporting peaked in 2021 at $73,380 and has fallen 87.5% since, to $9,149 in 2025. Among clinical cardiac electrophysiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 407 payments — averaging $436.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$78K
- Abbott$47K
- Johnson & Johnson$21K
- Boston Scientific$20K
- Biosense Webster, Inc.$5K
- Medical Device Business Services, Inc.$4K
- plus $2K from 17 others
What the payments were for
- Consulting fees$6,5504%
- Speaking & faculty fees$4,0252%
- Grants$145,40482%
- Travel & lodging$9,0315%
- Food & beverage$12,3277%
- Education$3220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 173 | $77,780 |
| Abbott | 105 | $47,099 |
| Johnson & Johnson(2 entities) | 2 | $21,475 |
| Boston Scientific | 8 | $20,198 |
| Biosense Webster, Inc. | 73 | $5,358 |
| Medical Device Business Services, Inc. | 3 | $3,930 |
| Biotronik Inc. | 14 | $780 |
| Altathera Pharmaceuticals LLC | 2 | $186 |
| Cardiva Medical, Inc. | 1 | $125 |
| Elutia, Inc. | 3 | $102 |
| Atricure, Inc. | 1 | $93 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $91 |
| E.r. Squibb & Sons, L.L.C. | 4 | $70 |
| Inari Medical, Inc. | 3 | $66 |
| Abiomed | 1 | $56 |
| Irhythm Technologies, Inc. | 1 | $51 |
| Baylis Medical Company Inc | 2 | $51 |
| Inspire Medical Systems, Inc. | 2 | $40 |
| Davol Inc. | 1 | $25 |
| Impulse Dynamics (USA) Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| ZOLL Respicardia, Inc. | 1 | $21 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$15,000
- Carto 3$7,289
- GENERAL BRADY$5,000
- ENSITE$4,282
- ENSITE PRECISION$1,220
- EVERA MRI XT DR SURESCAN$1,197
- AVEIR$1,042
- Micra$769
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$769
- Arctic Front$481
- AURORA EV-ICD MRI SURESCAN$356
- Adapta$322
- GALLANT$269
- Sotalol Hydrochloride$173
- AZURE XT DR MRI SURESCAN$172
- COBALT DR MRI SURESCAN$163
- NUVISION ICE CATHETER$148
- QDOT MICRO Catheter$148
- ASSURITY$144
- Cardiva VASCADE MVP VVCS 6-12F$125
How this compares
$177,659 in reported general payments places this provider in the 90th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 69 | $68,954 |
| XareltoRivaroxaban | 13 | $10,727 |
| Dofetilide | 32 | $2,072 |
| Flecainide Acetate | 32 | $914 |
| Potassium Chloride | 12 | $756 |
| Colchicine | 15 | $261 |
| Metoprolol Succinate | 27 | $236 |
| SotalolSotalol Hcl | 13 | $231 |
| Amiodarone Hcl | 28 | $188 |
| Furosemide | 15 | $14 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $21,475 | $10,72713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Austin
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Rodney HortonAustin$553K
- Robert CanbyAustin$224K
- David TschoppAustin$114K
- Mauricio HongAustin$79K
- Michael DelaughterBedford$1.6M
- Dale YooMcKinney$585K
- Jose Cuellar SilvaWebster$502K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.